Mebane Faber - Virtus LifeSci BioShares ETF Portfolio Manager

BBC Etf  USD 28.96  0.62  2.19%   
Mebane Faber is Portfolio Manager at Virtus LifeSci Biotech
IssuerVirtus
Inception Date2014-12-16
BenchmarkLifeSci Biotechnology Clinical Trials Index
Entity TypeRegulated Investment Company
Asset Under Management11.31 Million
Average Trading Valume5,666.9
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets

Similar Fund Executives

Showing other executives

One Year Return

Laird LandmannVanEck Mortgage REIT
N/A
Robert SmithVanEck Mortgage REIT
N/A
John LawVanEck Mortgage REIT
N/A
Darin TurnerDirexion Daily Industrials
N/A
Scott RadellVanEck Mortgage REIT
N/A
Hyunmi KimDirexion Daily Industrials
N/A
Jane QinDirexion Daily Industrials
N/A
David FishmanVanEck Mortgage REIT
N/A
George CaoDirexion Daily Industrials
N/A
Olga WinnerDirexion Daily Industrials
N/A
Lewis JohnsonVanEck Mortgage REIT
N/A
David McGarelVanEck Mortgage REIT
N/A
Blake GravesDirexion Daily Industrials
N/A
Ferian JuwonoVanEck Mortgage REIT
N/A
Jim SnyderDirexion Daily Industrials
N/A
Rachel AmesVanEck Mortgage REIT
N/A
Timothy SeymourVanEck Mortgage REIT
N/A
Ashraf RizviVanEck Mortgage REIT
N/A
Guangdong QiDirexion Daily Industrials
N/A
Wesley RagerDirexion Daily Industrials
N/A
Frank MietheVanEck Mortgage REIT
N/A
Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States. Virtus LifeSci Biotech [BBC] is traded in USA and was established 2014-12-16.

Virtus LifeSci Biotech Money Managers

Marques Mercier, BioShares ETF Portfolio Manager
Robert Galusza, BioShares ETF Portfolio Manager
Lisa Khatri, BioShares ETF Portfolio Manager
Ferian Juwono, BioShares ETF Portfolio Manager
Scott Baskind, BioShares ETF Portfolio Manager
Chris Peterson, BioShares ETF Portfolio Manager
Thomas Brussard, BioShares ETF Portfolio Manager
Frank Vallario, BioShares ETF Portfolio Manager
Richard Mejzak, BioShares ETF Portfolio Manager
Ryan Harder, BioShares ETF Portfolio Manager
Brandon Matsui, BioShares ETF Portfolio Manager
Brendan Sullivan, BioShares ETF Portfolio Manager
Adam Cohn, ETF Portfolio Manager
Michael Feehily, BioShares ETF Portfolio Manager
James Mauro, BioShares ETF Portfolio Manager
Brad Camden, BioShares ETF Portfolio Manager
Peter Spano, BioShares ETF Portfolio Manager
Matthew Krummell, BioShares ETF Portfolio Manager
Stephen Hammers, BioShares ETF Portfolio Manager
Ryan Dofflemeyer, BioShares ETF Portfolio Manager
Jay Hatfield, BioShares ETF Portfolio Manager
Stephanie Shu, BioShares ETF Portfolio Manager
Rob Bateman, BioShares ETF Portfolio Manager
Benjamin McAbee, BioShares ETF Portfolio Manager
Donald Butler, BioShares ETF Portfolio Manager
Saul Ballesteros, BioShares ETF Portfolio Manager
Ted Janowsky, BioShares ETF Portfolio Manager
Abhishek Kumar, BioShares ETF Portfolio Manager
James King, BioShares ETF Portfolio Manager
David Young, BioShares ETF Portfolio Manager
Devin Sullivan, BioShares ETF Portfolio Manager
James Stavena, BioShares ETF Portfolio Manager
Mike Doyle, BioShares ETF Portfolio Manager
Linda Killian, BioShares ETF Portfolio Manager
Laif Meidell, BioShares ETF Portfolio Manager
Charlotte Cipolletti, BioShares ETF Portfolio Manager
John Lewis, BioShares ETF Portfolio Manager
Louis Lu, ETF Portfolio Manager
Hans Albrecht, BioShares ETF Portfolio Manager
Rebecca Felton, BioShares ETF Portfolio Manager
William Coleman, BioShares ETF Portfolio Manager
Donal Bishnoi, BioShares ETF Portfolio Manager
Naveen Kumar, BioShares ETF Portfolio Manager
Christopher Lo, BioShares ETF Portfolio Manager
Julie Callahan, BioShares ETF Portfolio Manager
Joanna Madden, BioShares ETF Portfolio Manager
Matt Pappas, BioShares ETF Portfolio Manager
Paul Brigandi, BioShares ETF Portfolio Manager
David McGarel, BioShares ETF Portfolio Manager
Justin Hales, BioShares ETF Portfolio Manager
Rob Glownia, BioShares ETF Portfolio Manager
Rachel Ames, BioShares ETF Portfolio Manager
Tom Connelley, BioShares ETF Portfolio Manager
Dan Ahrens, ETF Portfolio Manager
Philip Fang, BioShares ETF Portfolio Manager
Teresa Zheng, BioShares ETF Portfolio Manager
Matthew Brown, BioShares ETF Portfolio Manager
Devin Ryder, ETF Portfolio Manager
Jeffrey Kernagis, BioShares ETF Portfolio Manager
Michael Przygoda, BioShares ETF Portfolio Manager
Jonathan Nixon, BioShares ETF Portfolio Manager
Scott Hanson, BioShares ETF Portfolio Manager
Ted Randall, Virtus ETF Portfolio Manager
Hayley Peppers, Virtus ETF Portfolio Manager
Bilal Memon, BioShares ETF Portfolio Manager
Amy Scofield, BioShares ETF Portfolio Manager
Tao Wang, BioShares ETF Portfolio Manager
Gary Stroik, BioShares ETF Portfolio Manager
Sabya Sinha, BioShares ETF Portfolio Manager
Greg Savage, BioShares ETF Portfolio Manager
Michael Chico, BioShares ETF Portfolio Manager
Benjamin Wang, BioShares ETF Portfolio Manager
Scott Fleming, BioShares ETF Portfolio Manager
Tim Anderson, BioShares ETF Portfolio Manager
Lisa Hobart, BioShares ETF Portfolio Manager
Stephen Smitley, Virtus ETF Portfolio Manager
Mark McKissick, BioShares ETF Portfolio Manager
David Chin, BioShares ETF Portfolio Manager
Grant Jackson, BioShares ETF Portfolio Manager
Nicolas Piquard, BioShares ETF Portfolio Manager
Taylor Ridgely, BioShares ETF Portfolio Manager
Benoit Autier, Virtus ETF Portfolio Manager
Joe Rodriguez, BioShares ETF Portfolio Manager
Albert Chuang, BioShares ETF Portfolio Manager
Daniel Hare, Virtus ETF Portfolio Manager
Tim Gramatovich, BioShares ETF Portfolio Manager
Vassilis Dagioglu, BioShares ETF Portfolio Manager
Cai Jing, BioShares ETF Portfolio Manager
Wade Guenther, BioShares ETF Portfolio Manager
Louis Bottari, BioShares ETF Portfolio Manager
Kevin Nicholson, BioShares ETF Portfolio Manager
Laurie Brignac, BioShares ETF Portfolio Manager
Wei Li, BioShares ETF Portfolio Manager
Patrick Bresnehan, BioShares ETF Portfolio Manager
Peter Zilver, BioShares ETF Portfolio Manager
Ernesto Tong, BioShares ETF Portfolio Manager
Ian Carroll, Virtus ETF Portfolio Manager
Daniel Ong, Virtus ETF Portfolio Manager
John Kaprich, Virtus ETF Portfolio Manager
Thomas Durante, BioShares ETF Portfolio Manager
Karen Wong, BioShares ETF Portfolio Manager
Dave Flaherty, BioShares ETF Portfolio Manager
Anand Desai, BioShares ETF Portfolio Manager
Timothy Henry, BioShares ETF Portfolio Manager
David Braun, BioShares ETF Portfolio Manager
Mark Blackburn, BioShares ETF Portfolio Manager
Michael Gates, BioShares ETF Portfolio Manager
Jon Erickson, BioShares ETF Portfolio Manager
Eric Maisel, BioShares ETF Portfolio Manager
Cyrille Conseil, Virtus ETF Portfolio Manager
Seth Kadushin, BioShares ETF Portfolio Manager
Oliver Furby, Virtus ETF Portfolio Manager
Alexander Ilyasov, BioShares ETF Portfolio Manager
Jim Iredale, BioShares ETF Portfolio Manager
Payal Gupta, BioShares ETF Portfolio Manager
Raymond Donofrio, BioShares ETF Portfolio Manager
Robert Regan, BioShares ETF Portfolio Manager
Garrett Paolella, BioShares ETF Portfolio Manager
Steven Boyd, ETF Portfolio Manager
David Albrycht, BioShares ETF Portfolio Manager
Jeremie Banet, BioShares ETF Portfolio Manager
Jeffrey Miller, BioShares ETF Portfolio Manager
Leonardo Costa, BioShares ETF Portfolio Manager
Jane Qin, BioShares ETF Portfolio Manager
Edward Tom, BioShares ETF Portfolio Manager
John Gardner, Virtus ETF Portfolio Manager
JeanDominique Butikofer, BioShares ETF Portfolio Manager
Luis Berruga, BioShares ETF Portfolio Manager
Andrea Roemhildt, Virtus ETF Portfolio Manager
Daniel Lindquist, BioShares ETF Portfolio Manager
Michael Finocchi, BioShares ETF Portfolio Manager
Philip Lee, BioShares ETF Portfolio Manager
Bryan Richards, BioShares ETF Portfolio Manager
Michael Foggin, BioShares ETF Portfolio Manager
Jeffrey Ploshnick, BioShares ETF Portfolio Manager
Beckham Wyrick, Virtus ETF Portfolio Manager
Lorne Johnson, BioShares ETF Portfolio Manager
Thomas Coleman, BioShares ETF Portfolio Manager
David Hammer, BioShares ETF Portfolio Manager
Matthew Tuttle, BioShares ETF Portfolio Manager
Samuel Masucci, BioShares ETF Portfolio Manager
Joseph Madrid, BioShares ETF Portfolio Manager
Michael Akins, BioShares ETF Portfolio Manager
Xiaochen Wang, BioShares ETF Portfolio Manager
Jon Poglitsch, BioShares ETF Portfolio Manager
Paul Curbo, BioShares ETF Portfolio Manager
Cindy Gao, BioShares ETF Portfolio Manager
Guo Jin, BioShares ETF Portfolio Manager
Eva Pao, BioShares ETF Portfolio Manager
Alfonso Portfillo, BioShares ETF Portfolio Manager
Andrew Hicks, BioShares ETF Portfolio Manager
Karl Schneider, BioShares ETF Portfolio Manager
Tanuj Dora, BioShares ETF Portfolio Manager
Joshua Barrickman, BioShares ETF Portfolio Manager
Shlomo Bassous, BioShares ETF Portfolio Manager
John Love, BioShares ETF Portfolio Manager
David Miller, BioShares ETF Portfolio Manager
Roger Bayston, BioShares ETF Portfolio Manager
Steve Kahler, BioShares ETF Portfolio Manager
Charles Ragauss, ETF Portfolio Manager
William Baird, BioShares ETF Portfolio Manager
Chuck Craig, BioShares ETF Portfolio Manager
David Rios, BioShares ETF Portfolio Manager
Ethan Chan, BioShares ETF Portfolio Manager
Joshua Emanuel, BioShares ETF Portfolio Manager
John Vecchio, BioShares ETF Portfolio Manager
Scott Fries, BioShares ETF Portfolio Manager
Mannik Dhillon, BioShares ETF Portfolio Manager
Andrew Serowik, Virtus ETF Portfolio Manager
Timothy Collins, BioShares ETF Portfolio Manager
Alex Pazdan, BioShares ETF Portfolio Manager
Frank Miethe, BioShares ETF Portfolio Manager
Paul Brown, BioShares ETF Portfolio Manager
William Smith, BioShares ETF Portfolio Manager
Diane Hsiung, BioShares ETF Portfolio Manager
Emiliano Rabinovich, BioShares ETF Portfolio Manager
Roger Testin, BioShares ETF Portfolio Manager
Anthony Routh, BioShares ETF Portfolio Manager
Deane Gyllenhaal, BioShares ETF Portfolio Manager
Alex Hamilton, Virtus ETF Portfolio Manager
Greg Barrato, BioShares ETF Portfolio Manager
Jennifer Hsui, BioShares ETF Portfolio Manager
Bradley Sullivan, BioShares ETF Portfolio Manager
Peter Yi, BioShares ETF Portfolio Manager
Anne Walsh, BioShares ETF Portfolio Manager
Denise Krisko, BioShares ETF Portfolio Manager
Sean Reichert, BioShares ETF Portfolio Manager
Michael Weaver, BioShares ETF Portfolio Manager
Robert Bauer, BioShares ETF Portfolio Manager
Timothy Furbush, BioShares ETF Portfolio Manager
Gerard OReilly, BioShares ETF Portfolio Manager
Steve Brown, BioShares ETF Portfolio Manager
Leo Fan, BioShares ETF Portfolio Manager
Michael Brunell, BioShares ETF Portfolio Manager
James Michal, BioShares ETF Portfolio Manager
Alexander Bridgeforth, BioShares ETF Portfolio Manager
Mitchell Firestein, Virtus ETF Portfolio Manager
Jerome Schneider, BioShares ETF Portfolio Manager
David Hallum, BioShares ETF Portfolio Manager
Kris Dorr, BioShares ETF Portfolio Manager
MultiManager, BioShares ETF Portfolio Manager
Patrick Dwyer, BioShares ETF Portfolio Manager
Jacob Borbidge, BioShares ETF Portfolio Manager
Tarak Dave, BioShares ETF Portfolio Manager
Andrew Ngim, BioShares ETF Portfolio Manager
Rafael Zayas, BioShares ETF Portfolio Manager
Brian Evans, BioShares ETF Portfolio Manager
James Harrison, BioShares ETF Portfolio Manager
Nam To, BioShares ETF Portfolio Manager
Robert Shimell, BioShares ETF Portfolio Manager
Francis Rodilosso, BioShares ETF Portfolio Manager
Duy Nguyen, BioShares ETF Portfolio Manager
Ray Allen, BioShares ETF Portfolio Manager
Michael Venuto, ETF Portfolio Manager
James Murchie, BioShares ETF Portfolio Manager
Don Schreiber, BioShares ETF Portfolio Manager
Joe Staines, BioShares ETF Portfolio Manager
Steven Hung, BioShares ETF Portfolio Manager
Awais Khan, BioShares ETF Portfolio Manager
Keith Richardson, BioShares ETF Portfolio Manager
Andrew Jessop, BioShares ETF Portfolio Manager
Michael Perre, BioShares ETF Portfolio Manager
Scott Radell, BioShares ETF Portfolio Manager
Tony Seisser, BioShares ETF Portfolio Manager
Christopher DiStefano, BioShares ETF Portfolio Manager
Richard Jenkins, BioShares ETF Portfolio Manager
Michael Johnson, BioShares ETF Portfolio Manager
Jeremiah Holly, BioShares ETF Portfolio Manager
HaoHung Liao, BioShares ETF Portfolio Manager
Eric Viliott, BioShares ETF Portfolio Manager
Stan Ueland, BioShares ETF Portfolio Manager
Richard Brown, BioShares ETF Portfolio Manager
Michael Kastner, ETF Portfolio Manager
Alan Mason, BioShares ETF Portfolio Manager
Paul Fusaro, BioShares ETF Portfolio Manager
Patrick Waddell, BioShares ETF Portfolio Manager
Ron Heller, BioShares ETF Portfolio Manager
Jonathan Sage, BioShares ETF Portfolio Manager
Paul Benson, BioShares ETF Portfolio Manager
Jonathan Guyer, BioShares ETF Portfolio Manager
Jonathan Molchan, BioShares ETF Portfolio Manager
Steven Hawkins, BioShares ETF Portfolio Manager
Chang Kim, BioShares ETF Portfolio Manager
Troy Cates, BioShares ETF Portfolio Manager
Jeff Peters, BioShares ETF Portfolio Manager
Kevin OShaughnessy, BioShares ETF Portfolio Manager
Thomas Connelley, BioShares ETF Portfolio Manager
Sanjay Gulati, BioShares ETF Portfolio Manager
Thomas Musmanno, BioShares ETF Portfolio Manager
Jeremy Neisewander, BioShares ETF Portfolio Manager
Adrian Bachman, BioShares ETF Portfolio Manager
Scott Glasing, BioShares ETF Portfolio Manager
Scott Geiger, BioShares ETF Portfolio Manager
Michelle Louie, BioShares ETF Portfolio Manager
Seth Misshula, BioShares ETF Portfolio Manager
Mark Schlarbaum, BioShares ETF Portfolio Manager
Jonathan Stanley, BioShares ETF Portfolio Manager
Daniel McMullen, BioShares ETF Portfolio Manager
Thomas Urano, BioShares ETF Portfolio Manager
Richard DarbyDowman, BioShares ETF Portfolio Manager
Mohit Mittal, BioShares ETF Portfolio Manager
Eric Richardson, BioShares ETF Portfolio Manager
James Francis, ETF Portfolio Manager
Mark MacQueen, BioShares ETF Portfolio Manager
Teddy Wong, BioShares ETF Portfolio Manager
Gold Corporation, Virtus ETF Portfolio Manager
James Colby, BioShares ETF Portfolio Manager
Kenneth Hyman, BioShares ETF Portfolio Manager
Steven Hlavin, BioShares ETF Portfolio Manager
Dan Banaszak, BioShares ETF Portfolio Manager
James Snyder, BioShares ETF Portfolio Manager
Ryan Mischker, BioShares ETF Portfolio Manager
Orlando Montalvo, BioShares ETF Portfolio Manager
Mark Krivitsky, BioShares ETF Portfolio Manager
William Housey, BioShares ETF Portfolio Manager
Danielle Salters, BioShares ETF Portfolio Manager
Timothy Ryan, BioShares ETF Portfolio Manager
Matthew Dorsten, BioShares ETF Portfolio Manager
Daniel Personette, BioShares ETF Portfolio Manager
Juan Acevedo, BioShares ETF Portfolio Manager
Kai Chen, BioShares ETF Portfolio Manager
Michael Jeanette, BioShares ETF Portfolio Manager
Christopher Wrazen, BioShares ETF Portfolio Manager
Brad Lamensdorf, BioShares ETF Portfolio Manager
Mark Okada, BioShares ETF Portfolio Manager
Daniel TenPas, BioShares ETF Portfolio Manager
Brandon Ferguson, BioShares ETF Portfolio Manager
Michelle Liu, BioShares ETF Portfolio Manager
Amy Cheng, BioShares ETF Portfolio Manager
Joseph Barrato, BioShares ETF Portfolio Manager
Ford ONeil, BioShares ETF Portfolio Manager
Mike Feehily, BioShares ETF Portfolio Manager
Patrick Klein, BioShares ETF Portfolio Manager
John Law, BioShares ETF Portfolio Manager
Rob Guttschow, BioShares ETF Portfolio Manager
Edward Ryan, BioShares ETF Portfolio Manager
Peter Matthew, BioShares ETF Portfolio Manager
Qiong Wan, BioShares ETF Portfolio Manager
Robert Guiliano, BioShares ETF Portfolio Manager
James Ong, BioShares ETF Portfolio Manager
Robert Anstine, BioShares ETF Portfolio Manager
John Reese, BioShares ETF Portfolio Manager
Michael Cudzil, BioShares ETF Portfolio Manager
Eduardo Repetto, Virtus ETF Portfolio Manager
Theodore Samulowitz, BioShares ETF Portfolio Manager
John Gambla, BioShares ETF Portfolio Manager
Stephen Rodosky, BioShares ETF Portfolio Manager
Derek Fulton, BioShares ETF Portfolio Manager
David Prothro, BioShares ETF Portfolio Manager
Olga Winner, BioShares ETF Portfolio Manager
Tony Ng, BioShares ETF Portfolio Manager
Walter Nejman, BioShares ETF Portfolio Manager
Robert Parker, ETF Portfolio Manager
David Hemming, BioShares ETF Portfolio Manager
Michael Plage, BioShares ETF Portfolio Manager
Marc DiCosimo, BioShares ETF Portfolio Manager
John Tysseland, BioShares ETF Portfolio Manager
Dustin Lewellyn, BioShares ETF Portfolio Manager
Linda Longville, BioShares ETF Portfolio Manager
William Flaig, BioShares ETF Portfolio Manager
Michael Byrum, BioShares ETF Portfolio Manager
Darin Turner, BioShares ETF Portfolio Manager
Kristi Henderson, BioShares ETF Portfolio Manager
John Gulino, BioShares ETF Portfolio Manager
Tom Futrell, BioShares ETF Portfolio Manager
Michael Loeffler, Virtus ETF Portfolio Manager
Catherine Wood, BioShares ETF Portfolio Manager
B Minerd, BioShares ETF Portfolio Manager
Nicholas DEramo, Virtus ETF Portfolio Manager
Robert Wolf, BioShares ETF Portfolio Manager
Yazann Romahi, BioShares ETF Portfolio Manager
Jim Snyder, BioShares ETF Portfolio Manager
Dwayne Hancock, BioShares ETF Portfolio Manager
Gordon McKemie, BioShares ETF Portfolio Manager
Kartik Aiyar, BioShares ETF Portfolio Manager
Nicholas Fischer, BioShares ETF Portfolio Manager
Gary Jones, BioShares ETF Portfolio Manager
David Swallow, BioShares ETF Portfolio Manager
Richard Ose, BioShares ETF Portfolio Manager
William DeRoche, BioShares ETF Portfolio Manager
Jack Forehand, BioShares ETF Portfolio Manager
George Chao, BioShares ETF Portfolio Manager
Navid Sohrabi, BioShares ETF Portfolio Manager
Garrett Herfkens, BioShares ETF Portfolio Manager
Celso Munoz, BioShares ETF Portfolio Manager
PingYing Wang, BioShares ETF Portfolio Manager
Johnathan Wilhelm, BioShares ETF Portfolio Manager
Mebane Faber, BioShares ETF Portfolio Manager
Michael Martel, BioShares ETF Portfolio Manager
Todd Larson, BioShares ETF Portfolio Manager
Christine Franquin, BioShares ETF Portfolio Manager
Daniel Hyman, BioShares ETF Portfolio Manager
Sean Lussier, BioShares ETF Portfolio Manager
Hozef Arif, BioShares ETF Portfolio Manager
William Decker, BioShares ETF Portfolio Manager
Ronald Martin, BioShares ETF Portfolio Manager
Kala ODonnell, BioShares ETF Portfolio Manager
Matthew Hastings, BioShares ETF Portfolio Manager
Melissa Kapitulik, BioShares ETF Portfolio Manager
Hailey Harris, BioShares ETF Portfolio Manager
David Kunselman, BioShares ETF Portfolio Manager
Michael Neches, BioShares ETF Portfolio Manager
Fred Zhang, ETF Portfolio Manager
Travis Trampe, BioShares ETF Portfolio Manager
Cynthia Moy, BioShares ETF Portfolio Manager
Orlando Purpura, BioShares ETF Portfolio Manager
Michael Jones, BioShares ETF Portfolio Manager
Scott Weiner, BioShares ETF Portfolio Manager
Orhan Imer, BioShares ETF Portfolio Manager
Bradley Camden, BioShares ETF Portfolio Manager
Peter Hubbard, BioShares ETF Portfolio Manager
Allan Smallwood, BioShares ETF Portfolio Manager
Christopher Bliss, BioShares ETF Portfolio Manager
Jon Guyer, BioShares ETF Portfolio Manager
Matthew Bartlett, BioShares ETF Portfolio Manager
Rebecca Valdez, BioShares ETF Portfolio Manager
Robert Cummings, Virtus ETF Portfolio Manager
James Kramer, BioShares ETF Portfolio Manager
Jeremiah Charles, BioShares ETF Portfolio Manager
Todd Bean, BioShares ETF Portfolio Manager
George Cao, BioShares ETF Portfolio Manager
Kyle Kelly, BioShares ETF Portfolio Manager
Guangdong Qi, BioShares ETF Portfolio Manager

Virtus Etf Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is Virtus LifeSci a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Virtus LifeSci in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Virtus LifeSci's short interest history, or implied volatility extrapolated from Virtus LifeSci options trading.

Pair Trading with Virtus LifeSci

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Virtus LifeSci position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virtus LifeSci will appreciate offsetting losses from the drop in the long position's value.

Moving together with Virtus Etf

  0.9XLV Health Care SelectPairCorr
  0.91VHT Vanguard Health CarePairCorr
  0.92XBI SPDR SP BiotechPairCorr
  0.86IHI IShares US MedicalPairCorr

Moving against Virtus Etf

  0.86BITI ProShares Trust -PairCorr
  0.43GREI Goldman Sachs FuturePairCorr
The ability to find closely correlated positions to Virtus LifeSci could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Virtus LifeSci when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Virtus LifeSci - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Virtus LifeSci Biotech to buy it.
The correlation of Virtus LifeSci is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Virtus LifeSci moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Virtus LifeSci Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Virtus LifeSci can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Virtus LifeSci Biotech. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Virtus LifeSci Biotech information on this page should be used as a complementary analysis to other Virtus LifeSci's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Virtus Etf analysis

When running Virtus LifeSci's price analysis, check to measure Virtus LifeSci's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virtus LifeSci is operating at the current time. Most of Virtus LifeSci's value examination focuses on studying past and present price action to predict the probability of Virtus LifeSci's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virtus LifeSci's price. Additionally, you may evaluate how the addition of Virtus LifeSci to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Share Portfolio
Track or share privately all of your investments from the convenience of any device
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.